Impact of CRISP on Self-Efficacy, Loneliness, and Depression
Effects of an Educational Socialization Program Designed to Improve Self-Efficacy and Subsequent Effects on Decreasing Loneliness and Depression Among People With Multiple Sclerosis
What it found
We found no results in the registry or in papers.
This trial finished 11 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- CRISP Program
Placebo
- Control Group
What it measured
Main measures
Multiple Sclerosis Self-Efficacy Scale (MSSS)
Change from Baseline to week 12
Other measures (4)
UCLA Revised Loneliness Scale
Change from Baseline to week 12
Chicago Multiscale Depression Inventory (CMDI)
Change from Baseline to week 12
Mood and sleepPerformance Scales (PS)
Change from Baseline to week 12
VisionThinking and memoryFatigueWalking and mobilityArm and hand functionPhysical functionSpasticityBladder, bowel and sexual functionPainMood and sleepCommunity Integration Questionnaire (CIQ)
Change from Baseline to week 12
Who could take part
MS (type not specified) · 18 to 65
Show the full criteria
Inclusion criteria
* Age 18 to 65 years old. * Must have a definitive diagnosis of MS by a physician. * Must understand English at 6th grade level since the CRISP program requires participants to comprehend the educational information presented in English. * Agree to participate in 12 group sessions over 12 weeks; * Must have the ability to complete questionnaires in English since the outcome measures used for the study are in English. * Must be able to commute to the site destinations
Exclusion criteria
* Have an actively psychotic Axis I disorder. * Have a significant Axis II disorder of borderline personality disorder or schizoid personality disorder. * Have a diagnosis of another neurological condition aside from MS. * Inability to comply with study requirements/visits.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The purpose of this study is to examine the effects of an innovative program, entitled CRISP (Community Integration for Socially Isolated Patients), on improving self-efficacy and assessing whether improved self-efficacy helps to reduce depression and loneliness of people with MS.
Loading reviews and guidelines…
History
Started
Feb 2014
Main results due
Dec 2014
Finished
Dec 2014